NasdaqGS - Nasdaq Real Time Price USD
Medpace Holdings, Inc. (MEDP)
302.88
+12.34
+(4.25%)
At close: 4:00:01 PM EDT
302.88
0.00
(0.00%)
After hours: 6:50:17 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 387,456 | 11 |
| Sales | 4,003 | 1 |
| Net Shares Purchased (Sold) | 383,453 | 12 |
| Total Insider Shares Held | 5.9M | -- |
| % Net Shares Purchased (Sold) | 7.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KRAFT ROBERT O Director | -- | Direct | -- | Mar 31, 2025 |
| CARLEY BRIAN T Director | -- | Direct | -- | Mar 31, 2025 |
| MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Mar 31, 2025 |
| TROENDLE AUGUST J Chief Executive Officer | Conversion of Exercise of derivative security at price 54.74 - 107.93 per share. | Direct | 24,458,835 | Mar 7, 2025 |
| EWALD STEPHEN P General Counsel | Purchase at price 326.11 per share. | Direct | 652 | Feb 27, 2025 |
| CARLEY BRIAN T Director | Conversion of Exercise of derivative security at price 42.62 per share. | Direct | 346,373 | Feb 24, 2025 |
| CARLEY BRIAN T Director | Sale at price 345.59 per share. | Direct | 1,383,397 | Feb 24, 2025 |
| KRAFT ROBERT O Director | -- | Direct | -- | Dec 31, 2024 |
| CARLEY BRIAN T Director | -- | Direct | -- | Dec 31, 2024 |
| MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Dec 31, 2024 |
| GEIGER JESSE J President | Conversion of Exercise of derivative security at price 32.05 per share. | Direct | 480,750 | Dec 6, 2024 |
| BURWIG SUSAN ELIZABETH Officer | Conversion of Exercise of derivative security at price 32.05 per share. | Direct | 240,375 | Nov 19, 2024 |
| KRAFT ROBERT O Director | -- | Direct | -- | Sep 30, 2024 |
| CARLEY BRIAN T Director | -- | Direct | -- | Sep 30, 2024 |
| MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Sep 30, 2024 |
| KRAFT ROBERT O Director | Conversion of Exercise of derivative security at price 42.62 per share. | Direct | 346,373 | Aug 23, 2024 |
| KRAFT ROBERT O Director | Sale at price 390.73 per share. | Direct | 3,175,463 | Aug 23, 2024 |
| BURWIG SUSAN ELIZABETH Officer | Conversion of Exercise of derivative security at price 90.65 per share. | Direct | 4,532,500 | Aug 5, 2024 |
| KRAFT ROBERT O Director | -- | Direct | -- | Jun 28, 2024 |
| CARLEY BRIAN T Director | -- | Direct | -- | Jun 28, 2024 |
| MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Jun 28, 2024 |
| BURWIG SUSAN ELIZABETH Officer | Sale at price 401.20 per share. | Direct | 3,081,617 | Jun 5, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 395.22 - 395.49 per share. | Direct | 3,828,058 | May 28, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.00 per share. | Direct | 22,000 | May 22, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.19 per share. | Direct | 1,608,764 | May 20, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 403.09 - 405.13 per share. | Direct | 15,924,222 | May 16, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 402.89 per share. | Direct | 1,996,723 | May 10, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.17 - 400.58 per share. | Direct | 3,310,566 | May 9, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 401.73 - 404.48 per share. | Direct | 21,129,347 | May 7, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.44 - 401.56 per share. | Direct | 6,553,671 | May 2, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 400.31 - 400.69 per share. | Direct | 6,782,987 | Apr 30, 2024 |
| KRAFT ROBERT O Director | -- | Direct | -- | Mar 28, 2024 |
| CARLEY BRIAN T Director | -- | Direct | -- | Mar 28, 2024 |
| MCCARTHY CORNELIUS P. III Director | -- | Direct | -- | Mar 28, 2024 |
| BURWIG SUSAN ELIZABETH Officer | Sale at price 403.00 per share. | Direct | 41,106 | Mar 15, 2024 |
| KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 84.36 per share. | Direct | 42,180 | Mar 14, 2024 |
| KEATING ASHLEY M. Director | Sale at price 409.87 per share. | Direct | 102,468 | Mar 14, 2024 |
| MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 408.71 - 412.98 per share. | Direct | 82,321,250 | Mar 8, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 408.71 - 412.98 per share. | Indirect | 82,321,250 | Mar 8, 2024 |
| KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 54.99 per share. | Direct | 25,955 | Mar 7, 2024 |
| KEATING ASHLEY M. Director | Sale at price 415.00 per share. | Direct | 195,880 | Mar 7, 2024 |
| GEIGER JESSE J President | Conversion of Exercise of derivative security at price 90.65 per share. | Direct | 3,626,000 | Mar 5, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 402.70 - 403.12 per share. | Indirect | 40,291,000 | Mar 5, 2024 |
| MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 402.70 - 403.12 per share. | Direct | 40,291,000 | Mar 5, 2024 |
| GEIGER JESSE J President | Sale at price 403.03 per share. | Direct | 8,996,033 | Mar 4, 2024 |
| TROENDLE AUGUST J Chief Executive Officer | Sale at price 393.71 - 401.88 per share. | Indirect | 40,024,600 | Mar 1, 2024 |
| MEDPACE INVESTORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 393.71 - 401.88 per share. | Direct | 40,024,600 | Mar 1, 2024 |
| EWALD STEPHEN P General Counsel | Sale at price 393.50 - 400.79 per share. | Direct | 597,923 | Mar 1, 2024 |
| GEIGER JESSE J President | Sale at price 393.50 per share. | Direct | 1,006,586 | Feb 29, 2024 |
| KEATING ASHLEY M. Director | Conversion of Exercise of derivative security at price 54.99 per share. | Direct | 27,495 | Feb 28, 2024 |
Related Tickers
TMO Thermo Fisher Scientific Inc.
426.66
-1.15%
DHR Danaher Corporation
196.50
+0.10%
ICLR ICON Public Limited Company
145.92
+1.96%
DGX Quest Diagnostics Incorporated
175.87
+1.33%
IQV IQVIA Holdings Inc.
150.68
+2.46%
IDXX IDEXX Laboratories, Inc.
440.98
+3.36%
MTD Mettler-Toledo International Inc.
1,075.00
+2.75%
CRL Charles River Laboratories International, Inc.
115.76
+6.20%
WAT Waters Corporation
340.70
+1.74%
ILMN Illumina, Inc.
77.61
+1.78%